Treatment of chronic HBeAg-positive hepatitis with acyclovir. A controlled trial (Q68162655)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3298405%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

title

Treatment of chronic HBeAg-positive hepatitis with acyclovir. A controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3298405%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

author name string

P Guarascio

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3298405%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

A P De Felici

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3298405%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

D Migliorini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3298405%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

G J Alexander

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3298405%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

E A Fagan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3298405%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

G Visco

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3298405%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

publication date

1 January 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3298405%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3298405%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

3 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3298405%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

S143-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3298405%20AND%20SRC:MED&resulttype=core&format=json

Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B Hepatitis

22 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980113-1

7 January 2021

Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine Arabinoside

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980113-1

7 January 2021

Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980113-1

7 January 2021

Spontaneous disappearance of viral replication and liver cell inflammation in HBsAg-positive chronic active hepatitis: results of a placebo vs. interferon trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980113-1

7 January 2021

Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980113-1

7 January 2021

Inhibition of human and woodchuck hepatitis virus DNA polymerase by the triphosphates of acyclovir, 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and E-5-(2-bromovinyl)-2'-deoxyuridine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980113-1

7 January 2021

Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980113-1

7 January 2021

Effect of liver disease on pharmacokinetics and toxicity of 9-beta-D-arabinofuranosyladenine-5-phosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980113-1

7 January 2021

Preliminary studies of acyclovir in chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980113-1

7 January 2021

Acyclovir in hepatitis B antigen-positive chronic liver disease: inhibition of viral replication and transient renal impairment with iv bolus administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980113-1

7 January 2021

Renal function after acyclovir intravenous injection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980113-1

7 January 2021

10.1016/S0168-8278(86)80113-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3298405%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference